ConductScience.org, home

Paper40951978

Rates of clinical progression according to biological Alzheimer's disease stages.

Trudel L and 23 others. Alzheimers Dement, 2025. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Rates of clinical progression according to biological Alzheimer's disease stages. Papers, record 40951978. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40951978

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rates of clinical progression according to biological Alzheimer's disease stages.
PubMed
Journal
Alzheimers Dement
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
2.37, provisional
iCite
Revised in PubMed
2026-09-25
PubMed

Authors24

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Trudel LLydiahttps://orcid.org/0009-0002-5593-7717
2Therriault JJoseph
3Macedo ACArthur C
4Servaes SStijn
5Hosseini SASeyyed Ali
6Bezgin GGleb
7Rahmouni NNesrine
8Chan TTevy
9Fernandez-Arias JJaime
10Aumont ÉÉtienne
11Wang YTYi-Ting
12Zheng YYansheng
13Hall BBrandon
14Hopewell RRobert
15Hsiao CHChris Hung-Hsin
16Toga AWArthur W
17Braskie MNMeredith N
18Meeker KLKarin L
19Soucy JPJean-Paul
20Gauthier SSerge

Source PubMed

See all 24 authorsDownload CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Disease ProgressionMajor topic
Alzheimer DiseaseMajor topic
Cognitive DysfunctionMajor topic
Humans
Male
Female
Aged
Positron-Emission Tomography
tau Proteins
Aged, 80 and over
Brain
Cohort Studies
Longitudinal Studies

Source PubMed

Download CSV of topics

Grants10

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
L60 AG096756NIA NIH HHSUnited StatesL60AG096756PubMedNIH RePORTER
Alzheimer's AssociationUnited StatesPubMedPubMed
P30 AG066530NIA NIH HHSUnited StatesP30AG066530PubMedNIH RePORTER
Weston Brain InstitutePubMedPubMed
Consortium canadien en neurodégénérescence associée au vieillissementPubMedPubMed
CIHRCanadaPubMedPubMed
Fondation Brain CanadaPubMedPubMed
Fonds de Recherche du Québec - SantéPubMedPubMed
P01 AG052350NIA NIH HHSUnited StatesP01AG052350PubMedNIH RePORTER
K01 AG083115NIA NIH HHSUnited StatesK01AG083115PubMedNIH RePORTER

Download CSV of grants

References61

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138482373Predicting functional decline in aging and Alzheimer's disease with PET-based Braak staging.Brain Commun2024https://conductscience.org/library/papers/38482373PubMed
222331215Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects.J Nucl Med2012https://conductscience.org/library/papers/22331215PubMed
332338734Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes.JAMA Neurol2020https://conductscience.org/library/papers/32338734PubMed
436516028Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patients.Alzheimers Dement2023https://conductscience.org/library/papers/36516028PubMed
539500009Identification of late-stage tau accumulation using plasma phospho-tau217.EBioMedicine2024https://conductscience.org/library/papers/39500009PubMed
626938442PET Imaging of Tau Deposition in the Aging Human Brain.Neuron2016https://conductscience.org/library/papers/26938442PubMed
740359457Validating the Amyloid Cascade Through the Revised Criteria of Alzheimer's Association Workgroup 2024 for Alzheimer Disease.Neurology2025https://conductscience.org/library/papers/40359457PubMed
832091549Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease.JAMA Neurol2020https://conductscience.org/library/papers/32091549PubMed
937321820The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework.J Nucl Med2023https://conductscience.org/library/papers/37321820PubMed
1031211344Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia.JAMA2019https://conductscience.org/library/papers/31211344PubMed
1111255443Mild cognitive impairment represents early-stage Alzheimer disease.Arch Neurol2001https://conductscience.org/library/papers/11255443PubMed
1234189247The Health & Aging Brain among Latino Elders (HABLE) study methods and participant characteristics.Alzheimers Dement (Amst)2021https://conductscience.org/library/papers/34189247PubMed
1339740074Clinical use of biomarkers in the era of Alzheimer's disease treatments.Alzheimers Dement2025https://conductscience.org/library/papers/39740074PubMed
1439776249Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup.Alzheimers Dement2025https://conductscience.org/library/papers/39776249PubMed
1526194311The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015.Alzheimers Dement2015https://conductscience.org/library/papers/26194311PubMed
1622749065Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.Lancet Neurol2012https://conductscience.org/library/papers/22749065PubMed
1727042901Mild Cognitive Impairment.Continuum (Minneap Minn)2016https://conductscience.org/library/papers/27042901PubMed
1831157827Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study.JAMA Neurol2019https://conductscience.org/library/papers/31157827PubMed
1935327650Multicenter 18F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer's Disease.Biomolecules2022https://conductscience.org/library/papers/35327650PubMed
2040986433Implication for Clinical Trials From Longitudinal Tau-PET Accumulation Across Biological Alzheimer Disease Stages.Neurology2025https://conductscience.org/library/papers/40986433PubMed

See all 61 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42923225Noninvasive diagnosis of Alzheimer's disease: a review of emerging biomarkers and multimodal approaches.Front Cell Dev Biol2026https://conductscience.org/library/papers/42923225PubMed
42889489Comparison of brain-derived versus conventional pTau biomarkers in CSF and plasma for detecting Alzheimer's disease.Brain Commun2026https://conductscience.org/library/papers/42889489PubMed
42557955Predicting continuous amyloid PET levels with CSF and plasma brain-derived p-tau217.Alzheimers Dement2026https://conductscience.org/library/papers/42557955PubMed
42448890Using CA1 rather than the whole hippocampus to capture tau-PET Braak stage II.Eur J Nucl Med Mol Imaging2026https://conductscience.org/library/papers/42448890PubMed
42255958Eligibility for anti-amyloid treatment in a multiethnic community-based study.Alzheimers Dement (Amst)2026https://conductscience.org/library/papers/42255958PubMed
42168643Visual versus quantitative tau-PET Braak staging in Alzheimer's disease using [18F]MK6240.Eur J Nucl Med Mol Imaging2026https://conductscience.org/library/papers/42168643PubMed
41963989Continuum of Core 1 biomarkers in preclinical Alzheimer's disease.Alzheimers Res Ther2026https://conductscience.org/library/papers/41963989PubMed
41667430Should all MCI with Alzheimer's biological diagnosis receive anti-amyloid therapy?Cell Death Dis2026https://conductscience.org/library/papers/41667430PubMed
41556545Clinical-biological Alzheimer's disease stage concordance: insights from cohorts and autopsy data.Brain2026https://conductscience.org/library/papers/41556545PubMed
41266593APOE ε4 potentiates tau related reactive astrogliosis assessed by cerebrospinal fluid YKL40 in Alzheimer's disease.Commun Med (Lond)2025https://conductscience.org/library/papers/41266593PubMed
40951978Rates of clinical progression according to biological Alzheimer's disease stages.Alzheimers Dement2025https://conductscience.org/library/papers/40951978PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APP351PubTator's text mininghttps://conductscience.org/library/genes/351NCBI Gene
MAPT4137PubTator's text mininghttps://conductscience.org/library/genes/4137NCBI Gene
SNCA6622PubTator's text mininghttps://conductscience.org/library/genes/6622NCBI Gene
TARDBP23435PubTator's text mininghttps://conductscience.org/library/genes/23435NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40951978

GET https://conductscience.org/api/papers/v1/40951978/authors?page=2